So far in his second term, President Donald Trump has been trying to coerce international corporations to bolster their spending in the United States, including through his controversial tariffs. | President Donald Trump's recent executive order on drug prices threatens Roche's ability to fund the tens of billions of U.

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United States, the company said on Wednesday. Trump's order, signed Monday, directs drugmakers to lower prices of brand-name medicines to align with those in other wealthy nations.